The Ukravit Group, a large producer of plant protection agents and micro-fertilizers in Ukraine, has started working in the pharmaceutical and food supplements sphere.
“We entered Chemical Elements Ukraine as owners and partners. This is a Cherkasy-based producer and exporter of raw materials for the pharmaceutical market, former Khimreaktiv. We entered this company with 30% [of shares]. Starting this year we are working in the new sphere for us – pharmaceutical,” Marketing Director Anatoliy Kalantarian told reporters during the ceremony to open a research and development center in Cherkasy.
At the same time, he said that Ukravit intends to produce biologically pure supplements, which in the future will be exported. “We are already negotiating deliveries with some countries, including with the Middle East,” Kalantarian said. According to him, the intellectual base for creating products will be in the research center, production capacities will be new and located in Cherkasy.
In addition, Kalantarian said that in 2019, Ukravit will start selecting their own hybrids of seeds, as well as work on the creation of bio-pesticides. “We are going to cooperate with international scientific institutions when developing products. We are already working with the institute from Switzerland. We are negotiating with Spain, Israel and the United States. We have strategic plans for cooperation with the global scientific community,” he said.
Ukravit is engaged in production and sale of pesticides, fertilizers with microelements, means for destruction of rodents and domestic insects. The group includes Factory of Agrochemicals LLC (Cherkasy) which produces plant protection agents and micro-fertilizers. It produces more than 150 items of products.
Ukraine in January-February 2018 considerably increased exports of medicines to Russia, cutting their imports from the country. According to the State Statistics Service, in January-February 2018, Ukraine exported medicines for $3.5 million to Russia, which is 18% more than a year ago. Imports of medicines from Russia to Ukraine over the period fell by 40.4%, to $2.85 million.
Last year Ukraine exported medicines to Russia for $27.89 million, which is 31.9% more than a year ago, and imported medicines for $29.79 million from Russia (15.9% down). In 2017, Ukraine exported medicines for $171.17 million, including to the CIS for $143.057 million.
As reported, at present, because of the sanctions imposed on Russia, Russia is discussing the ways of replacing imported medicines and reducing dependence on foreign pharmaceutical companies. The decline in the imports of Russian medicines to Ukraine began after the introduction of the requirement of compliance of drugs with GMP standards in Ukraine.
Ukrainian pharmaceutical manufacturers have noted the need to resolve a number of issues related to the filling and application of the national list of essential medicines. Marketing and Sales Director of PJSC Farmak Susana Khalilova noted at present market participants do not have clear understanding of whether there will be the expansion of nosologies, according to which international nonproprietary names (INN) are included in the list, as well as the expansion of the number of molecules on the nosologies already included in the list.
“Currently we have the opportunity to apply for molecules, but we do not understand how we can justify the introduction [of drugs] for new nosologies, for example such as infertility, diabetes insipidus,” she said at a press conference at Interfax-Ukraine. Khalilova also emphasized the need to return the Fast Track procedure and simplify the introduction of changes regarding INN included in the list.
Commenting on the problem of applying the updated list at the local level, in particular the norm on 100% compulsory provision with drugs from it, she noted the difficulty of “how the coverage of this 100% need can be showed.”
Head of InterChem-Pharma Trading House Oleksandr Chumak, in turn, expressed the opinion about the need to approve such an edition of the list that would allow the Ukrainian market to plan its production.